Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 11, 2023

BUY
$35.86 - $46.5 $537,900 - $697,500
15,000 New
15,000 $609,000
Q2 2022

Aug 05, 2022

SELL
$53.22 - $123.09 $1.35 Million - $3.12 Million
-25,366 Closed
0 $0
Q1 2022

May 11, 2022

SELL
$101.89 - $150.09 $646,186 - $951,870
-6,342 Reduced 20.0%
25,366 $2.95 Million
Q4 2021

Feb 11, 2022

BUY
$118.18 - $153.21 $1.65 Million - $2.14 Million
14,000 Added 79.06%
31,708 $4.77 Million
Q1 2021

May 12, 2021

SELL
$81.28 - $104.34 $999,093 - $1.28 Million
-12,292 Reduced 40.97%
17,708 $1.56 Million
Q3 2020

Nov 06, 2020

SELL
$95.43 - $116.09 $4.32 Million - $5.26 Million
-45,300 Reduced 60.16%
30,000 $3.41 Million
Q2 2020

Aug 12, 2020

SELL
$60.05 - $98.92 $1.78 Million - $2.94 Million
-29,700 Reduced 28.29%
75,300 $7.45 Million
Q1 2020

May 12, 2020

BUY
$47.37 - $90.04 $3.08 Million - $5.85 Million
65,000 Added 162.5%
105,000 $6.76 Million
Q4 2019

Feb 10, 2020

SELL
$53.13 - $71.19 $106,260 - $142,380
-2,000 Reduced 4.76%
40,000 $2.38 Million
Q3 2019

Oct 30, 2019

BUY
$57.11 - $73.3 $571,100 - $733,000
10,000 Added 31.25%
42,000 $2.48 Million
Q2 2019

Jul 29, 2019

SELL
$54.41 - $71.7 $2.34 Million - $3.08 Million
-43,000 Reduced 57.33%
32,000 $2.07 Million
Q1 2019

May 14, 2019

SELL
$32.25 - $73.56 $806,250 - $1.84 Million
-25,000 Reduced 25.0%
75,000 $4.76 Million
Q4 2018

Feb 05, 2019

SELL
$28.45 - $40.65 $1.14 Million - $1.63 Million
-40,000 Reduced 28.57%
100,000 $3.8 Million
Q3 2018

Nov 13, 2018

SELL
$21.39 - $51.17 $1.82 Million - $4.35 Million
-85,000 Reduced 37.78%
140,000 $6 Million
Q2 2018

Aug 13, 2018

BUY
$4.9 - $23.64 $1.1 Million - $5.32 Million
225,000 New
225,000 $4.96 Million

Others Institutions Holding TNDM

About TANDEM DIABETES CARE INC


  • Ticker TNDM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 64,221,200
  • Market Cap $2.37B
  • Description
  • Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...
More about TNDM
Track This Portfolio

Track Granite Point Capital Management, L.P. Portfolio

Follow Granite Point Capital Management, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Granite Point Capital Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Granite Point Capital Management, L.P. with notifications on news.